Skip to main content
Unichem Laboratories Ltd. logo

Unichem Laboratories Ltd. — Investor Relations & Filings

Ticker · UNICHEMLAB ISIN · INE351A01035 LEI · 3358008AHXLO9H4C2Q20 BSE.NS Manufacturing
Open in API
Filings indexed 1,118 across all filing types
Latest filing 2023-11-01 Regulatory Filings
Country IN India
Listing BSE.NS UNICHEMLAB

About Unichem Laboratories Ltd.

https://www.unichemlabs.com/

Unichem Laboratories Ltd. focuses on the research, development, manufacturing, and marketing of pharmaceutical formulations and Active Pharmaceutical Ingredients (APIs). The company provides solutions across various therapeutic areas, including cardiology, gastroenterology, anti-infectives, diabetology, orthopedics, and neurology. It maintains a significant international footprint, exporting products to regulated markets such as the United States and Europe. The manufacturing infrastructure is built to comply with global standards, featuring approvals from international regulatory agencies. Through its dedicated research and development initiatives, the organization develops a robust pipeline of generic products and complex formulations aimed at improving patient outcomes globally.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2023-11-01 English
We would like to inform you that Board of Directors at its Meeting held today, i.e. Wednesday, November 1, 2023, approved the Unaudited Financial Results (Standalone & Consolidated) for ....
Regulatory Filings
2023-11-01 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding issuance of duplicate share certificates due to loss of original certificates. It is addressed to stock exchanges and mentions procedural compliance with SEBI circulars. The content is a regulatory announcement about share certificate status and related administrative actions, not a financial report, meeting material, or management discussion. The document length is short (2210 characters) and it does not contain financial data or report results. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-10-19 English
Compliance under Reg.(3) - intimation of loss of share certificate.
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss of original certificates by shareholders. It references compliance with SEBI regulations and details about the stop transfer of shares. The content is a regulatory announcement related to share certificate management and does not contain financial statements, management discussion, or report publication. The document length is short (2210 characters) and it is an intimation under a specific SEBI regulation. This fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories like share issue or director dealings.
2023-10-19 English
Board Meeting — UNICHEM LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 01-Nov-2023 to inter-alia consider and approve the Unaudited Financial results of the Company…
Regulatory Filings
2023-10-18 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about a scheduled Board Meeting on November 1, 2023, to consider and approve the unaudited financial results for the second quarter and six months ended September 30, 2023. It is an intimation or announcement of an upcoming event rather than the financial results themselves. The document is short (1637 characters) and serves as a notice under SEBI regulations. Therefore, it is not the actual Interim/Quarterly Report but an announcement related to it. According to the classification rules, such announcements are best classified under Regulatory Filings (RNS) as they do not contain substantive financial data or the report itself.
2023-10-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.